ブンシ ドウリキガクホウ オヨビ ミツド ハンカンスウホウ オ モチイタ CYP2D6 ニオケル チオリダジン ノ タイシャ キコウ ニ カンスル ケンキュウ by 笹原, 克則
様式 7
論 文 内 容 要 旨
報　告
番　号
甲 創 第 号 氏 　 名
学位論文題目
分子動力学法及び密度汎関数法を用いたCYP2D6における
チオリダジンの代謝機構に関する研究
笹原 克則
Figure 2. Calculated equilibrium binding
poses (orange) together with 
crystallographic ones (dark). 
Figure 1. THD, Compound I, and 
Asp301.  *: asymmetric carbon 
Cytochrome P450s (CYPs) is now known to exist in multiple 
forms and to play important roles in the oxidation of endogenous 
substrates such as androgens and  estrogens for biofunctional 
control (Sasahara K et al., J. Neurosci. (2007)) as well as 
tremendous range of drugs (Sasahara K et al., Drug. Metab. 
Dispos. (2015)). In fact, CYPs are involved in the catalysis of 
approximately 75% of drug metabolism reactions, suggesting 
CYPs are most important drug-metabolizing enzymes. 
Therefore it is important to clarify the metabolic profiles and 
mechanism of drugs. CYP2D6 is second most responsible for 
the CYP-mediated metabolism. Thioridazine (THD) is one of 
the phenothiazine-type antipsychotics, which exhibit dopamine 
D2 antagonistic activity. THD shows characteristic metabolic 
profiles compared to other phenothiazine-type antipsychotics 
such as chlorpromazine. The sulfur atom attached to the phenothiazine ring is preferentially oxidized 
mainly by CYP2D6, i.e. the 2-sulfoxide is a major metabolite, and interestingly this metabolite shows 
more potent activity against dopamine D2 receptors than THD. On the other hand, the formation of this 
metabolite causes many serious problems for its clinical use. Recently, Wang et al. revealed the 
crystallographic structure of THD with CYP2D6. In the current study, in vitro metabolic profiles of THD 
with CYP2D6 as well as other CYP isozymes were experimentally examined using LC-UV-MS/MS 
under experimental concentrations closer to the effective blood ones. At the same time, the binding and 
reaction mechanisms at the atomic and electronic levels were computationally examined based on the 
assumption as to whether or not the different crystallographic 
binding poses correspond to the different metabolites. The 
binding and oxidative reaction steps in the whole metabolic 
process were investigated using molecular dynamics (MD) 
and density functional theory (DFT) calculations, respectively. 
The observed metabolites and crystallographic binding poses 
can be related to each other by means of MD and DFT 
calculations. The results presented here will act as links 
between crystallographic, dynamic, and kinetic pictures, and 
the observed metabolism of THD with CYP2D6. The current 
study demonstrated the essential importance of the 
orientation of the substrate in the reaction center of 
CYP2D6 for the metabolic reaction (from Sasahara K et al., Bioorg. Med. Chem. (2015)).  
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